NCT02550418View on ClinicalTrials.gov

Budesonide 9 mg Capsules in Active UC

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Colitis, Ulcerative
Interventions
DRUG

Budesonide

Trial Locations (1)

23538

University of Schleswig-Holstein, Lübeck

Sponsors
All Listed Sponsors
lead

Dr. Falk Pharma GmbH

INDUSTRY